FisclearFisclear

Financial Comparison

Dr. Reddy's Laboratories Limited vs Sun Pharmaceutical Industries Limited

Click a ticker to view the full analysis.

DRREDDY.NS vs

In short

Sun Pharmaceutical Industries Limited is the more profitable of the two, keeping 19.7% of revenue as net profit against 12.8% for Dr. Reddy's Laboratories Limited. Sun Pharmaceutical Industries Limited trades at the higher trailing P/E (35.2× vs 30.5× for Dr. Reddy's Laboratories Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Dr. Reddy's Laboratories Limited and 0 for Sun Pharmaceutical Industries Limited.

Based on filings for periods ending 31 Mar 2026 (DRREDDY.NS) and 31 Mar 2026 (SUNPHARMA.NS) · Updated

FisclearScore Comparison

DRREDDY.NS55Fair
SUNPHARMA.NS68Strong
Quality+11
83
94
Efficiency+15
47
62
Value+36
26
62
Cashflow+7
63
56
Regime
55
55
Peers+19
51
70

FisclearScore is a quantitative model. DRREDDY.NS shown solid · SUNPHARMA.NS shown dashed. Not financial advice.

MetricDRREDDY.NSSUNPHARMA.NS
Price₹1,188.00₹1,772.00
Market Cap₹989.6B₹4.25T
P/E (TTM)30.5x35.2x
P/B2.6x5.1x
Beta0.250.14
Div Yield0.65%0.91%
Revenue (TTM)₹335.9B₹582.2B
Net Income₹42.9B₹114.8B
Gross Margin52.8%77.4%
Risk Flags1 flag—
Full DRREDDY.NS Report →Full SUNPHARMA.NS Report →

Related comparisons

CIPLA.NS vs Sun PharmaceuticalDIVISLAB.NS vs Sun PharmaceuticalAPOLLOHOSP.NS vs Sun PharmaceuticalSun Pharmaceutical vs TORNTPHARM.NSCIPLA.NS vs Dr. Reddy's LaboratoriesDIVISLAB.NS vs Dr. Reddy's Laboratories

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.